RECURSION PHARMACEUTICALS, INC. (CIK: 0001601830) EDGAR, Information, Filings... CompaniesBIO.Com

RECURSION PHARMACEUTICALS, INC.

Mailing address
41S RIO GRANDE STREET, SALT LAKE CITY, Delaware, 84101
Phone
(385) 269-0203
State location
Utah
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

RECURSION PHARMACEUTICALS, INC. (CIK: 0001601830) is an American company incorporated in the state of Utah. Head office is located at 41S RIO GRANDE STREET, SALT LAKE CITY, Utah, 84101. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). RECURSION PHARMACEUTICALS, INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

Recursion Pharmaceuticals, LLC from 2014-02-Apr to 2015-04-Dec

Owner	Filings	Transaction Date	Type of Owner
Mauro David J	0001621172	Jun-01-2023	officer: Chief Medical Officer
Lux Ventures IV, L.P.	0001633331	Dec-07-2021	other: Former 10% Owner
Lux Venture Partners IV, LLC	0001633332	Dec-07-2021	other: Former 10% Owner
Hebert Peter	0001683771	Dec-07-2021	other: Former 10% Owner
Lux Co-Invest Partners, LLC	0001722021	Dec-07-2021	other: Former 10% Owner
Lux Co-Invest Opportunities, L.P.	0001722022	Dec-07-2021	other: Former 10% Owner
Wolfe Josh	0001830001	Dec-07-2021	other: Former 10% Owner
Dar Zavain	0001852075	Dec-07-2021	director
MIC Capital Partners (Public) Parallel Cayman, LP	0001775215	Nov-01-2021	10 percent owner
MIC Capital Management UK LLP	0001889830	Nov-01-2021	10 percent owner
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC	0001770682	Apr-16-2021	10 percent owner
CHAVEZ R. MARTIN	0001157983	Apr-15-2021	director
HERSHBERG ROBERT	0001274139	Apr-15-2021	director
Mamoura Diversified Global Holding PJSC	0001419351	Apr-15-2021	10 percent owner
Data Collective IV, L.P.	0001664972	Apr-15-2021	10 percent owner
Data Collective IV GP, LLC	0001664974	Apr-15-2021	10 percent owner
DCVC Opportunity Fund II GP, LLC	0001668343	Apr-15-2021	10 percent owner
DCVC Opportunity Fund II, L.P.	0001668344	Apr-15-2021	10 percent owner
Mubadala Investment Co PJSC	0001704268	Apr-15-2021	10 percent owner
DCVC V GP, LLC	0001770616	Apr-15-2021	10 percent owner
DCVC V, L.P.	0001770617	Apr-15-2021	10 percent owner
Burrell Terry-Ann	0001786484	Apr-15-2021	director
Ocko Matthew	0001836089	Apr-15-2021	10 percent owner
Bogue Zachary	0001836157	Apr-15-2021	director, 10 percent owner
Li Dean Y	0001837016	Apr-15-2021	director
Secora Michael	0001855980	Apr-15-2021	officer: Chief Financial Officer
Doyle Ramona	0001856069	Apr-15-2021	officer: Chief Medical Officer
Virani Shafique	0001856081	Apr-15-2021	officer: Chief Corp. Dev. Officer
Borgeson Blake	0001856094	Apr-15-2021	director
Gibson Christopher	0001856369	Apr-15-2021	director, 10 percent owner, officer: Chief Executive Officer
Larson Tina Marriott	0001856414	Apr-15-2021	officer: President and COO

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by RECURSION PHARMACEUTICALS, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-006192 (33 Act) Size: 7 KB	Sep-03-2024	001-40323 241274456
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000150 ( Act) Size: 16 KB	Sep-03-2024
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001601830-24-000149 (34 Act) Size: 15988 KB	Sep-03-2024	001-40323 241272044
8-K	Document	Current report filing Acc-no: 0001601830-24-000148 (34 Act) Size: 16459 KB	Sep-03-2024	001-40323 241272038
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000145 ( Act) Size: 18 KB	Aug-30-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-006080 (33 Act) Size: 6 KB	Aug-29-2024	001-40323 241264502
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000144 ( Act) Size: 18 KB	Aug-29-2024
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001601830-24-000142 (34 Act) Size: 111 KB	Aug-28-2024	001-40323 241256197
8-K	Document	Current report filing Acc-no: 0001601830-24-000140 (34 Act) Size: 249 KB	Aug-28-2024	001-40323 241256140
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-038664 ( Act) Size: 18 KB	Aug-28-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-038532 ( Act) Size: 18 KB	Aug-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-038438 ( Act) Size: 18 KB	Aug-26-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000130 ( Act) Size: 18 KB	Aug-23-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000129 ( Act) Size: 5 KB	Aug-22-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-005822 (33 Act) Size: 7 KB	Aug-20-2024	001-40323 241225482
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000128 ( Act) Size: 13 KB	Aug-19-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000127 ( Act) Size: 7 KB	Aug-19-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000126 ( Act) Size: 17 KB	Aug-19-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000125 ( Act) Size: 13 KB	Aug-19-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001601830-24-000123 ( Act) Size: 20 KB	Aug-15-2024

Recent 20 filings. View all RECURSION PHARMACEUTICALS, INC. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

RECURSION PHARMACEUTICALS, INC. overview
RECURSION PHARMACEUTICALS, INC. job
RECURSION PHARMACEUTICALS, INC. stock
RECURSION PHARMACEUTICALS, INC. ownership
RECURSION PHARMACEUTICALS, INC. CEO
RECURSION PHARMACEUTICALS, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.